Sientra (NASDAQ:SIEN) Shares Pass Above Fifty Day Moving Average of $0.92

Sientra, Inc. (NASDAQ:SIENGet Rating) shares crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.92 and traded as high as $1.11. Sientra shares last traded at $1.06, with a volume of 565,541 shares.

Analyst Ratings Changes

SIEN has been the subject of a number of recent research reports. StockNews.com downgraded shares of Sientra from a “hold” rating to a “sell” rating in a research note on Tuesday, May 10th. Lake Street Capital initiated coverage on shares of Sientra in a research note on Thursday, April 14th. They set a “buy” rating and a $8.00 price target for the company. Maxim Group reissued a “buy” rating and set a $5.00 price target on shares of Sientra in a research note on Friday, May 13th. Finally, Canaccord Genuity Group dropped their price target on shares of Sientra from $8.00 to $5.00 in a research note on Friday, May 13th. One investment analyst has rated the stock with a sell rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $7.29.

Sientra Price Performance

The company has a debt-to-equity ratio of 2.61, a current ratio of 1.59 and a quick ratio of 0.95. The stock has a market cap of $66.40 million, a P/E ratio of -1.07 and a beta of 1.94. The company’s 50 day simple moving average is $0.92 and its 200 day simple moving average is $1.77.

Sientra (NASDAQ:SIENGet Rating) last issued its earnings results on Thursday, May 12th. The medical instruments supplier reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.03). Sientra had a negative net margin of 71.61% and a negative return on equity of 498.54%. The firm had revenue of $21.40 million during the quarter, compared to the consensus estimate of $20.25 million. As a group, equities analysts forecast that Sientra, Inc. will post -0.93 earnings per share for the current year.

Institutional Investors Weigh In On Sientra

Several large investors have recently made changes to their positions in SIEN. Mirabella Financial Services LLP acquired a new position in Sientra during the first quarter worth $26,000. Advisor Group Holdings Inc. boosted its holdings in Sientra by 230.9% during the first quarter. Advisor Group Holdings Inc. now owns 11,930 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 8,325 shares during the last quarter. ProShare Advisors LLC acquired a new position in Sientra during the fourth quarter worth $47,000. Paradigm Financial Partners LLC acquired a new position in Sientra during the fourth quarter worth $50,000. Finally, Campbell & CO Investment Adviser LLC boosted its holdings in Sientra by 38.0% during the fourth quarter. Campbell & CO Investment Adviser LLC now owns 28,700 shares of the medical instruments supplier’s stock worth $105,000 after purchasing an additional 7,900 shares during the last quarter. Institutional investors own 82.42% of the company’s stock.

About Sientra

(Get Rating)

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

See Also

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.